The Effects of Captopril on Endothelial Cell Secreting of T-Pa and PAI-1

CHENG Xu-jie,LI Hong-xia,YANG Xiang-jun,CHEN Tan,XUE Feng,LIU Zhi-hua,JIANG Wen-ping
DOI: https://doi.org/10.3969/j.issn.1008-8199.2005.z1.001
2005-01-01
Abstract:Objective: To investigate the effects of captopril on fibrolytic balance. Methods: Cultivated ECV304 cells were stimulated with TNF-α(5,10,25,50,100 μg)and AngⅡ(5,10,25,50,100 nmol/L) for 24 hours. The same cells were also co-incubated with TNF-α(ng/ml)and captopril(20,50,100,200 nmol/L). Tissue-type plasminogen activator(t-PA) and plasminogen activator inhibitor-1 (PAI-1) in the supernatant were measured by enzyme linked immunosorbent assay (ELISA). Results: The concentrations of t-PA had no statistically significant changes in all supernatant of cultivated cells. But PAI-1 was significantly increased by Ang Ⅱ and TNF-α at same concentration. The PAI-1 secreting, induced by TNF-α, can be inhibited by captopril. Conclusion: Captopril has no effect on t-PA releasing from endo-thelial cells. TNF-α can increase PAI-1 secreting, but captopril can counteract this effect.
What problem does this paper attempt to address?